Tamoxifen and malignant epithelial–nonepithelial tumours of the endometrium: report of six cases and review of the literature

This publication has 52 references indexed in Scilit:

• Tamoxifen for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• Different Coexisting Endometrial Histological Features in Asymptomatic Postmenopausal Breast Cancer Patients Treated with Tamoxifen
  Gynecologic and Obstetric Investigation, 1997
• Time-Dependent Effect of Tamoxifen Therapy on Endometrial Pathology in Asymptomatic Postmenopausal Breast Cancer Patients
  International Journal of Gynecological Pathology, 1996
• Postmenopausal Tamoxifen Treatment and Endometrial Pathology
  Obstetrical & Gynecological Survey, 1994
• Continuous Tamoxifen Treatment in Asymptomatic, Postmenopausal Breast Cancer Patients Does Not Cause Aggravation of Endometrial Pathologies
  Gynecologic Oncology, 1994
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• What do we know and what don't we know about tamoxifen in the human uterus
  Breast Cancer Research and Treatment, 1994
• Endometrial lesions in patients undergoing tamoxifen therapy
  International Journal of Gynecology & Obstetrics, 1991
• Effects of Tamoxifen on the Female Genital Tract
  Annals of the New York Academy of Sciences, 1991
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989